Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych CASC / OSCEConsultation-liaison psychiatry

Psych CASC / OSCE · Consultation-liaison psychiatry

Explaining depression treatment and tamoxifen antidepressant choice — CASC communication station

MRCPsych/FRANZCP-style station: explain depression in cancer, collaborative care, safe antidepressant choice with tamoxifen, suicide risk without stigma, and delirium as a medical syndrome.

communication2 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 52-year-old woman with breast cancer on tamoxifen has major depression. Her partner is angry that 'psychiatry wants antidepressants that will make the cancer worse' after reading about drug interactions online. She also asks whether feeling she would be 'better off dead' means she is weak, and whether night-time confusion last admission means she is 'losing her mind forever.'

Station brief

Format. Communication station, approximately 7–10 minutes after reading time. You are the psychiatry registrar in the oncology clinic. The patient has major depression and is on tamoxifen; her partner attends.[1][5]

Candidate instructions. Explain that depression in cancer is common and treatable, not a moral failure. Outline collaborative care and a tamoxifen-aware antidepressant plan (avoid strong CYP2D6 inhibitors such as paroxetine/fluoxetine). Address death wishes compassionately with a safety plan. Explain prior night confusion as likely delirium — medical and often temporary — not permanent "madness." Check understanding and agree next steps with oncology.[1][2][3][4]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this CASC / OSCE. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Kelly CM, Juurlink DN, Gomes T, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study BMJ, 2010.PMID 20142325
  2. [2]Sharpe M, Walker J, Holm Hansen C, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial Lancet, 2014.PMID 25175478
  3. [3]Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis N Engl J Med, 2012.PMID 22475594
  4. [4]Agar MR, Lawlor PG, Quinn S, et al. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial JAMA Intern Med, 2017.PMID 27918778
  5. [5]Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer BMJ, 2018.PMID 29695476
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplaining demoralisation, adjustment, and mood treatment in medical illness — CASC communication stationConsultation-liaison psychiatryNextExplaining HAND, depression treatment, and ART interactions — CASC communication stationConsultation-liaison psychiatry